Ghika J, Goy J J, Naegeli C, Regli F
Service de Neurologie, CHUV, Lausanne, Switzerland.
Schweiz Arch Neurol Psychiatr (1985). 1994;145(1):4-6.
A 73 year-old patient with Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia developed an acute reversible encephalopathy within 15 days of initiation of flecainide. The clinical picture was characterized by visual hallucinations, agitation, anxiety, but no disorientation, and a severe cerebello-myoclonic syndrome with total inability to stand up and walk, which was fully reversible on discontinuing the medication.
一名患有预激综合征和阵发性室上性心动过速的73岁患者,在开始服用氟卡尼15天内出现急性可逆性脑病。临床表现为视幻觉、烦躁、焦虑,但无定向障碍,以及严重的小脑肌阵挛综合征,完全无法站立和行走,停药后完全可逆。